Feifei Pu
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
Papers in
-
- Cancer-related molecular mechanisms research 6
- MicroRNA in disease regulation 5
-
- Sarcoma Diagnosis and Treatment 18
- Co-authors
- Fengxia Chen (21 shared papers)Zengwu Shao (19 shared papers)Zengwu Shao (26 shared papers)Jianxiang Liu (23 shared papers)Baichuan Wang (14 shared papers)Xin Huang (8 shared papers)Doudou Jing (8 shared papers)Zhicai Zhang (14 shared papers)
- Journals
- Genes & Diseases (6 papers)OncoTargets and Therapy (5 papers)International Orthopaedics (3 papers)BMC Cancer (2 papers)International Journal of Oncology (2 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Feifei Pu
81 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 89
- Drug Discovery 5
- Cancer Research 131
- Rheumatology 114
- Pulmonary and Respiratory Medicine 205
- Pathology and Forensic Medicine 102
Countries citing papers authored by Feifei Pu
This map shows the geographic impact of Feifei Pu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feifei Pu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feifei Pu more than expected).
Fields of papers citing papers by Feifei Pu
This network shows the impact of papers produced by Feifei Pu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feifei Pu. The network helps show where Feifei Pu may publish in the future.
Co-authors
The 25 scholars most cited alongside Feifei Pu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 87 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 154 | |
| 2 | 2017 | 86 | |
| 3 | 2020 | 67 | |
| 4 | 2022 | 53 | |
| 5 | 2016 | 52 | |
| 6 | 2021 | 50 | |
| 7 | 2021 | 37 | |
| 8 | 2023 | 36 | |
| 9 | 2021 | 31 | |
| 10 | 2019 | 30 | |
| 11 | 2022 | 30 | |
| 12 | 2014 | 29 | |
| 13 | 2021 | 29 | |
| 14 | 2019 | 28 | |
| 15 | 2017 | 27 | |
| 16 | 2022 | 26 | |
| 17 | 2015 | 24 | |
| 18 | 2024 | 24 | |
| 19 | 2017 | 22 | |
| 20 | 2019 | 20 |
About Feifei Pu
Feifei Pu is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Rheumatology, Pathology and Forensic Medicine and Oncology, having authored 87 papers that have together received 1.3k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (18 papers), Bone Tumor Diagnosis and Treatments (10 papers), Spine and Intervertebral Disc Pathology (8 papers), Cancer-related molecular mechanisms research (6 papers), MicroRNA in disease regulation (5 papers), Infectious Diseases and Tuberculosis (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Management of metastatic bone disease (4 papers). The work is most often cited by research in Drug Discovery (5 citations), Cancer Research (131 citations), Rheumatology (114 citations), Pulmonary and Respiratory Medicine (205 citations) and Pathology and Forensic Medicine (102 citations). Feifei Pu has collaborated with scholars based in China and United States. Frequent co-authors include Fengxia Chen, Zengwu Shao, Zengwu Shao, Jianxiang Liu, Baichuan Wang, Xin Huang, Doudou Jing, Zhicai Zhang, Haoyu Guo and Weiyue Zhang. Their work appears in journals such as Genes & Diseases, OncoTargets and Therapy, International Orthopaedics, BMC Cancer and International Journal of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.